Azole Resistance in Candida glabrata

Area of Science:

• Mycology
• Antimicrobial Resistance
• Molecular Biology

Background:

• Increasing incidence of Candida infections in susceptible populations.
• Fluconazole, a widely used azole antifungal, faces challenges due to rising clinical resistance in Candida glabrata.
• Understanding azole resistance mechanisms is crucial for effective antifungal therapy.

Approach:

• Reviewing the molecular and genetic basis of azole resistance in Candida glabrata.
• Focusing on recent discoveries regarding resistance mechanisms.
• Investigating the role of multidrug transporters and the Pdr1 transcription factor.

Key Points:

• The most common mechanism of azole resistance in Candida glabrata is the overexpression of multidrug transporters.
• Activating mutations in the gene encoding the transcription factor Pdr1 lead to this overexpression.
• This mechanism significantly reduces the efficacy of fluconazole.

Conclusions:

• Elucidating the molecular underpinnings of azole resistance in Candida glabrata is essential.
• This knowledge can help in developing strategies to overcome resistance.
• Reclaiming azole antifungals for empiric treatment of Candida infections is a primary goal.